Behavioral and psychiatric differences in medication side effects in adults with severe intellectual disabilities

Journal of Mental Health Research in Intellectual Disabilities

Volumn 2, Issue 4, 2009, Pages 261-278

  Matson, Johnny L ^a   Fodstad, Jill C ^a   Rivet, Tessa T ^a   Rojahn, Johannes ^b  

^a LOUISIANA STATE UNIVERSITY   (United States)

^b GEORGE MASON UNIVERSITY   (United States)

Author keywords

Adults; BPI 01; DASH II; Intellectual disabilities; MEDS; Psychotropic medications; Side effects

Indexed keywords

EID: 85009577643     PISSN: 19315864     EISSN: 19315872     Source Type: Journal    
DOI: 10.1080/19315860903082615     Document Type: Article

References (40)

1. Advokat, C. D., Mayville, E. A., & Matson, J. L. (2000). Side effect profiles of atypical antipsychotics, typical antipsychotics, or no psychotropic medications in persons with mental retardation. Research in Developmental Disabilities, 21, 75-84.
2. American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (4th ed., Text Revision). Washington, DC: Author.
3. Appelgate, H., Matson, J. L., & Cherry, K. E. (1999). An evaluation of functional variables affecting severe problem behaviors in adults with mental retardation by using the Questions About Behavioral Function Scale (QABF). Research in Developmental Disabilities, 20, 229-237.
4. Cherry, K. E., Matson, J. L., & Paclawskyj, T. R. (1997). Psychopathology in older adults with severe and profound mental retardation. American Journal on Mental Retardation, 101, 445-458.
5. Dawson, J. E., Matson, J. L., & Cherry, K. E. (1998). An analysis of maladaptive behaviors in persons with autism, PDD-NOS, and mental retardation. Research in Developmental Disabilities, 19, 439-448.
6. Duncan, D., Matson, J. L., Bamburg, J. W., Cherry, K. E., & Buckley, T. (1999). The relationship of self-injurious behavior and aggression to social skills in persons with severe and profound learning disability. Research in Developmental Disabilities, 20, 441-448.
7. Emerson, E., & Bromley, J. (1995). The form and function of challenging behaviors. Journal of Intellectual Disability Research, 39, 338-398.
8. Facon, B. (2008). A cross-sectional test of the similar-trajectory hypothesis among adults with mental retardation. Research in Developmental Disabilities, 29, 29-44.
9. Farran, E. K. (2008). Strategies and biases in location memory in Williams syndrome. Research in Developmental Disabilities, 29, 385-397.
10. Field, A. P. (2004). Discovering statistics using SPSS (2nd ed.). London: Sage.
11. Holden, B., & Gitlesen, J. P. (2008). The relationship between psychiatric symptomatology and motivation of challenging behavior: A preliminary study. Research in Developmental Disabilities, 29, 408-413.
12. Matson, J. L. (1995). The Diagnostic Assessment for the Severely Handicapped Revised (DASH-II). Baton Rouge, LA: Disability Consultants, LLC.
13. Matson, J. L. (1998a). Diagnostic Assessment for the Severely Handicapped II-manual. Baton Rouge, LA: Disability Consultants, LLC.
14. Matson, J. L. (1998b). Matson Evaluation of Drug Side-effects (MEDS). Baton Rouge, LA: Disability Consultants, LLC.
15. Matson, J. L., Anderson, S. J., & Bamburg, J. W. (2000). The relationship of social skills to psychopathology for individuals with mild and moderate mental retardation. British Journal of Developmental Disabilities, 46, 15-22.
16. Matson, J. L., Bamburg, J. W., Cherry, K. E., & Paclawskyj, T. R. (1999). A validity study on the Questions About Behavioral Function (QABF) scale: Predicting treatment success for self-injury, aggression, and stereotypies. Research in Developmental Disabilities, 20, 163-176.
17. Matson, J. L., Bamburg, J. W., Mayville, E. A., & Logan, J. R. (2000). Tardive dyskinesia and developmental disabilities: An examination of demographics and topography in persons with dual diagnosis. British Journal of Developmental Disabilities, 46, 119-130.
18. Matson, J. L., Bamburg, J. W., Mayville, E. A., Pinkston, J., Bielecki, J., Kuhn, D., et al. (2000). Psychopharmacology and mental retardation: A 10 year review (1990-1999). Research in Developmental Disabilities, 21, 263-296.
19. Matson, J. L., Bielecki, J., Mayville, S. B., & Matson, M. L. (2003). Psychopharmacology research for individuals with mental retardation: Methodological issues and suggestions. Research in Developmental Disabilities, 24, 149-157.
20. Matson, J. L., Fodstad, J. C., & Rivet, T. T. (2008). The convergent and divergent validity of the Matson Evaluation of Drug Side Effects and the Dyskinesia Identification System Condensed User Scale (DISCUS). Journal of Intellectual and Developmental Disabilities, 33, 337-344.
21. Matson, J. L., & LoVullo, S. V. (2008). A review of behavioral treatments for selfinjurious behaviors of persons with autism spectrum disorders. Behavior Modification, 32, 61-76.
22. Matson, J. L., Mayville, E. A., Bamburg, J. W., & Eckholdt, C. S. (2001). An analysis of side-effect profiles of anti-seizure medications in persons with intellectual disability using the Matson Evaluation of Drug Side Effects (MEDS). Journal of Intellectual and Developmental Disability, 26, 283-295.
23. Matson, J. L., Mayville, E. A., Bielecki, J., Barnes, W. H., Bamburg, J. W., & Baglio, C. S. (1998). Reliability of the Matson Evaluation of Drug Side Effects (MEDS). Research in Developmental Disabilities, 19, 501-506.
24. Matson, J. L., Rivet, T. T., & Fodstad, J. C. (2008). Psychometric properties and participant characteristics for persons with intellectual disability using the Matson Evaluation of Drug Side-effects (MEDS). Journal of Developmental and Physical Disabilities, 20, 243-255.
25. Matson, J. L., Rivet, T. T., & Fodstad, J. C. (2009). Matson Evaluation of Drug Sideeffects (MEDS) profiles of Selective Serotonin Reuptake Inhibitors (SSRI) in adults with intellectual disability. Journal of Developmental and Physical Disabilities, 21, 57-68.
26. Matson, J. L., & Smiroldo, B. B. (1997). Validity of the Mania subscale of the Diagnostic Assessment for the Severely Handicapped-II (DASH-II). Research in Developmental disabilities, 18, 221-225.
27. Matson, J. L., Smiroldo, B. B., Hamilton, M., & Baglio, C. S. (1997). Do anxiety disorders exist in persons with severe and profound mental retardation? Research in Developmental Disabilities, 18, 39-44.
28. Matson, J. L., & Wilkins, J. (2008). Antipsychotic drug use for the aggression of persons with intellectual disability. The Lancet, 371, 9-10.
29. McGillivray, J. A., & McCabe, M. P. (2004). Pharmacological management of challenging behavior of individuals with intellectual disability. Research in Developmental Disabilities, 25, 523-537.
30. Nøttestad, J. A., & Linaker, O. M. (2008). Psychotropic drug use among people with intellectual disability before and after deinstitutionalization. Journal of Intellectual Disability Research, 47, 464-471.
31. Paclawskyj, T. R., Matson, J. L., Bamburg, J. W., & Baglio, C. S. (1997). A comparison of the Diagnostic Assessment for the Severely Handicapped-II (DASH-II) and the Aberrant Behavior checklist (ABC). Research in Developmental Disabilities, 18, 289-298.
32. Paclawskyj, T. R., Matson, J. L., Rush, K. S., Smalls, Y., & Vollmer, T. R. (2000). Questions About Behavioral Function (QABF): A behavioral checklist for functional assessment of aberrant behavior. Research in Developmental Disabilities, 21, 223-229.
33. Ringdahl, J. E., Call, N. A., Mews, J. B., Boelter, E. W., & Christensen, T. J. (2008). Assessment and treatment of aggressive behavior without a clear social function. Research in Developmental Disabilities, 29, 351-363.
34. Rojahn, J., Matson, J. L., Lott, D., Esbensen, A. J., & Smalls, Y. (2001). The Behavior Problems Inventory: An instrument for the assessment of self-injury, stereotyped behavior and aggression/destruction in individuals with developmental disabilities. Journal of Autism and Developmental Disorders, 31, 577-588.
35. Sparrow, S., Balla, D., & Cicchetti, D. V. (1984). The Vineland Adaptive Behavior Scales (survey form). Circle Pines, MN: American Guidance Service.
36. Stolker, J. J., Koedoot, P. J., Heerdink, E. R., Leufkens, H. G. M., & Nolen, W. A. (2003). Psychotropic drug use by mentally retarded persons with behavioural problems residing in care homes. Tijdschrift voor Psychiatrie, 45, 667-676.
37. Sturmey, P., Laud, R. B., Cooper, C. L., & Matson, J. L. (in press). Mania and behavioral equivalents: A preliminary study. Journal of Intellectual Disability Research.
38. Taylor, J. L., Novaco, R. W., Gilmer, B. T., Robertson, A., & Thorne, I. (2005). Individual cognitive-behavioral anger treatment for people with mild-borderline intellectual disabilities and histories of aggression: A controlled trial. British Journal of Clinical Psychology, 44, 367-392.
39. Tyrer, P., Oliver-Africano, P. C., Ahmed, Z., Bouras, N., Cooray, S., Ded, S., et al. (2008). Risperidone, haloperidol, and placebo in the treatment of aggressive challenging behavior in patients with intellectual disability: A randomized controlled trial. The Lancet, 371, 57-63.
40. World Health Organization Collaborating Centre for Drug Statistics Methodology (2007). ATC/DDD Index 2007. Retrieved October 26, 2007 from http://www.whocc.no/atcddd